Advanced melanoma patients with high CD16+ macrophages have better response and survival to anti-PD-1 based immunotherapy — H. Lee (2019) | RDL Network
Hansol Lee, Angela L. Ferguson, Camelia Quek, Ismael A. Vergara, Inês Pires da Silva, Ruth Allen, Tuba N. Gide, Jordan W. Conway, Lambros T. Koufariotis, Nicholas K. Hayward, Nicola Waddell, Matteo S. Carlino, Alexander M. Menzies, Robyn P.M. Saw, Elena Shklovskaya, Helen Rizos, Serigne Lo, Richard A Scolyer, Georgina V. Long, Umaimainthan Palendira, James S. Wilmott
Richard A Scolyer, Tuba N. Gide, Jason Madore, Alexander M. Menzies, Rebecca Dent, Matteo S. Carlino, Alexander Guminski, R.P.M. Saw, John F. Thompson, Guoxian Long, James S. Wilmott, H. Lee
Tuba N. Gide, Camelia Quek, Jason Madore, Alexander M. Menzies, Rebecca Dent, Matteo S. Carlino, Alex Guminski, Robyn P.M. Saw, John F. Thompson, Richard A Scolyer, Georgina V. Long, James S. Wilmott
C. Owen, Xue Bai, Gaik Tin Quah, Serigne Lo, Clara Allayous, Sophia Callaghan, Clara Martínez-Vila, Roslyn Wallace, Prachi Bhave, Irene L. M. Reijers, Nicola Thompson, Vito Vanella, Camille L. Gérard, Sandrine Aspeslagh, Alice Labianca, Adnan Khattak, Mario Mandalà, Wen Xu, Bart Neyns, Olivier Michielin, Christian U. Blank, Sarah J. Welsh, Andrew Haydon, Shahneen Sandhu,
Su Yin Lim, Jenny Lee, Tuba N. Gide, Alexander M. Menzies, Alexander Guminski, Matteo S. Carlino, Edmond J. Breen, Jean Yang, Shila Ghazanfar, Richard A Scolyer, Georgina V. Long, Helen Rizos
Discussion(0)
No comments yet. Be the first to comment.